Background
Head and neck squamous cell carcinoma (HNSCC) is an aggressive disease with an unpredictable prognosis. Failure of first-line treatment is common, thus additional therapeutic options are in great need. The purpose of this study was to explore biomarker expression profiles of HNSCC for therapeutic strategies that are not commonly pursued.